These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 18782028)

  • 1. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity.
    Deng C; Radu C; Diab A; Tsen MF; Hussain R; Cowdery JS; Racke MK; Thomas JA
    J Immunol; 2003 Mar; 170(6):2833-42. PubMed ID: 12626533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of autoimmune encephalomyelitis by toll-like receptors.
    Marta M; Meier UC; Lobell A
    Autoimmun Rev; 2009 May; 8(6):506-9. PubMed ID: 19211042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis.
    Paterka M; Voss JO; Werr J; Reuter E; Franck S; Leuenberger T; Herz J; Radbruch H; Bopp T; Siffrin V; Zipp F
    J Autoimmun; 2017 Jan; 76():108-114. PubMed ID: 27707650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
    Steckner C; Weber A; Mausberg AK; Heininger M; Opdenhövel F; Kieseier BC; Hartung HP; Hofstetter HH
    Clin Immunol; 2016 Sep; 170():22-30. PubMed ID: 27233983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The link between IL-23 and Th17 cell-mediated immune pathologies.
    McGeachy MJ; Cua DJ
    Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell recruitment and activation in autoimmunity.
    Sozzani S; Del Prete A; Bosisio D
    J Autoimmun; 2017 Dec; 85():126-140. PubMed ID: 28774715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between effector Th17 and regulatory T cells.
    Awasthi A; Murugaiyan G; Kuchroo VK
    J Clin Immunol; 2008 Nov; 28(6):660-70. PubMed ID: 18810613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of IL-17- and interferon-gamma-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp/IFA with pertussis toxin in SJL mice.
    Hofstetter HH; Forsthuber TG
    Neurosci Lett; 2010 Jun; 476(3):150-5. PubMed ID: 20398738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory Trained Immunity Mediated by Helminth Products Attenuates the Induction of T Cell-Mediated Autoimmune Disease.
    Quinn SM; Cunningham K; Raverdeau M; Walsh RJ; Curham L; Malara A; Mills KHG
    Front Immunol; 2019; 10():1109. PubMed ID: 31178861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory effects of Toll-like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris.
    Gao C; Liu M; Xin Y; Zeng Y; Yang H; Fan X; Zhao C; Zhang B; Zhang L; Li JJ; Zhao M; Wang Z; Lu Q
    Clin Transl Med; 2024 Jul; 14(7):e1765. PubMed ID: 39031979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases.
    Moudgil KD
    Cytokine; 2015 Jul; 74(1):1-4. PubMed ID: 26026376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.